← The Wire
GYRENasdaq
GYRE THERAPEUTICS, INC.
Pharmaceutical Preparations · DE · CIK 1124105
Develops and commercializes small-molecule therapies for organ fibrosis and inflammatory diseases
red 8-K · 90d
$575M
Market cap
$6.45
Last close
+2.5%
1D
+5.2%
5D
80K
Volume
Price · last 39 sessions-18.6%
May 4L $5.56 · H $8.04Jun 29
386
Total filings
Jun 16, 2026
Last filing
12/31
Fiscal year end
SC 13GSC 13GMar 4, 2022SC 13GSCHEDULE 13GFeb 11, 2022SC 13GSC 13GFeb 11, 2022SC 13GSC 13GJan 18, 2022SC 13GSC 13GJan 18, 2022SC 13GSC 13GFeb 16, 2021SC 13GSC 13GFeb 2, 2021SC 13GSC 13GAug 6, 2020SC 13GSC 13GAug 6, 2020SC 13GSC 13GAug 5, 2020SC 13GSCHEDULE 13GFeb 12, 2020SC 13GSCHEDULE 13GFeb 11, 2020SC 13GSC 13GJul 15, 2019SC 13GSC 13GMay 14, 2019SC 13GTHE SCHEDULE 13GMar 1, 2019SC 13GSCHEDULE 13GFeb 14, 2019SC 13GSC 13GFeb 14, 2019SC 13GSC 13GFeb 8, 2019SC 13GSC 13GAug 2, 2018SC 13GSCHEDULE 13GJun 25, 2018SC 13GJUNE 6, 2018Jun 11, 2018SC 13GSC 13GFeb 16, 2018SC 13GSC 13GFeb 14, 2018SC 13GSC 13GFeb 14, 2018SC 13GSC 13GFeb 14, 2018SC 13GCATALYST BIOSCIENCES, INC.Feb 12, 2018SC 13GSC 13GFeb 5, 2018SC 13GSC 13GJan 29, 2018SC 13GDECEMBER 21, 2017Dec 27, 2017SC 13GSC 13GApr 19, 2017SC 13GSC 13GApr 13, 2017SC 13GSCHEDULE 13GAug 28, 2015SC 13GSCHEDULE 13GAug 21, 2015SC 13GSC 13GJun 11, 2014
Similar companies
Comparable business profile · signals at a glance